DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Funds / Oxford Bioscience Partners V L.P.
Oxford Bioscience Partners V L.P.
Amounts, each with its basis
- Vintage
- unknownno dated first sale or first report yet
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- unknownwhat may be sold, not what was raised
- Form D sold
- unknown
- First sale
- unknown
- Reported GAV
- $86,176on the Form ADV filed Jan 9, 2019; the fund's assets, never its size or dry powder
- Owners (ADV)
- 22
- Reported on ADV
- Mar 30, 2012 to Jan 9, 2019
Fundraising evidence
Unknown
no Form D or close on record (fr-1)
A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Unknown
no vintage and no recent Form D
first sale: n/avintage year: n/aadv gav as of: 2019-01-09vintage basis: n/aform d sold usd: n/aform d offering usd: n/aform d latest filed at: n/a
The fund's own reporting through time
12 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 30, 2012 | Venture Capital Fund | $114M | 22 | $500,000 | 2% | yes | |
| Jun 26, 2012 | Venture Capital Fund | $114M | 22 | $500,000 | 2% | yes | |
| Jul 26, 2012 | Venture Capital Fund | $114M | 22 | $500,000 | 2% | yes | |
| Mar 27, 2013 | Venture Capital Fund | $74.1M | 22 | $500,000 | 2% | yes | |
| Nov 1, 2013 | Venture Capital Fund | $74.1M | 22 | $500,000 | 2% | yes | |
| Mar 28, 2014 | Venture Capital Fund | $74.1M | 22 | $500,000 | 2% | yes | |
| Mar 24, 2015 | Venture Capital Fund | $74.1M | 22 | $500,000 | 2% | yes | |
| Mar 3, 2016 | Venture Capital Fund | $20.4M | 22 | $500,000 | 2% | yes | |
| Feb 27, 2017 | Venture Capital Fund | $20.4M | 22 | $500,000 | 2% | yes | |
| Jan 2, 2018 | Venture Capital Fund | $20.4M | 22 | $500,000 | 2% | yes | |
| Jan 17, 2018 | Venture Capital Fund | $86,176 | 22 | $500,000 | 2% | no | |
| Jan 9, 2019 | Venture Capital Fund | $86,176 | 22 | $500,000 | 2% | no |
Principals and agents
0 principals on Form D, 0 placement agents
No Form D related person on record.
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
1 events
- Mar 30, 2012Oxford Bioscience Partners V L.P. first reported on Form ADV by Oxford Bioscience III Corporation (Venture Capital Fund), GAV $114,132,710Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Evidence
0 observations